BD PosiFlush, BD 306549Recalls & reported problems
Becton, Dickinson And Company · SYRINGE 3ML SALINE 3ML FILL W/BPC · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00382903065493), received between Jan 27, 2020 and Jan 27, 2020 — classified as 1 malfunction.
The most frequently reported specific device problem is “Volume Accuracy Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Volume Accuracy Problem1
Patient problems
- Underdose1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 27, 2020Volume Accuracy Problem; Volume Accuracy Problem
IT WAS REPORTED THAT THE ENTIRE FLUSH WAS NOT DELIVERED WITH THE SYRINGE 3ML SALINE 3ML FILL W/BPC DURING USE, WITH ONLY "0.4ML" DELIVERED INSTEAD OF THE "0.6ML" PROGRAMMED. THIS COMPLAINT WAS CREATED TO CAPTURE THE 3RD OF 3 RELATED INCIDENTS. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "WE HAVE RECENTLY SWITCHED OVER FROM HAVING 0.45% NORMAL SALINE FLUSHES THAT ARE PREPARED IN OUR PHARMACY TO THE 3ML 0.9% NORMAL SALINE FLUSHES THAT ARE FROM BD. SINCE THE SWITCH I HAVE BEEN GETTING CONCERNS BROUGHT TO ME FROM OUR NURSING STAFF ABOUT THE ENTIRE FLUSH AMOUNT NOT BEING DELIVERED THAT WAS PROGRAMMED. AFTER A MEETING ON MONDAY SOME OF THE NURSES DECIDED TO TEST IT OUT AND, FROM WHAT THEY WERE ABLE TO MEASURE, ONLY 0.4ML WAS DELIVERED EACH TIME INSTEAD OF THE 0.6ML THAT WAS PROGRAMMED."
Patient problems: Underdose
MAUDE report 9635047 ↗
Other Catheter,intravascular,therapeutic,short-term less than 30 days devices
- BD Insyte Autoguard 382523Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days660 reports
- BD Insyte Autoguard 382533Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days2 recalls527 reports
- BD PosiFlush 306546Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days1 death608 reports
- BD Insyte Autoguard Shielded IV Catheter 381823Becton, Dickinson And Company · Catheter, intravascular, therapeutic, short-term less than 30 days582 reports
- BD Insyte Autoguard 381423Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days1 recall528 reports
- BD Insyte Autoguard 382544Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days1 recall437 reports
- BD Nexiva, BD Q-Syte 383536Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days2 recalls374 reports
- BD PosiFlush 306547Becton, Dickinson And Company · Catheter,intravascular,therapeutic,short-term less than 30 days2 recalls1 death331 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page